<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Bramble: Ofer Shina</title>
    <link>https://news.ketelle.co.uk/entities/ofer-shina</link>
    <description>Stories involving Ofer Shina, told neutrally, with how each side covers them.</description>
    <language>en-gb</language>
    <atom:link href="https://news.ketelle.co.uk/entities/ofer-shina/feed.xml" rel="self" type="application/rss+xml"/>
    <item>
      <title>Israeli PSEN1 gene carrier founds Florida startup on Ben-Gurion University Parkinson's drug research</title>
      <link>https://news.ketelle.co.uk/stories/israeli-carrier-of-psen1-alzheimer-s-gene-takes-ben-gurion-university-</link>
      <guid isPermaLink="true">https://news.ketelle.co.uk/stories/israeli-carrier-of-psen1-alzheimer-s-gene-takes-ben-gurion-university-</guid>
      <pubDate>Tue, 17 Nov 2026 14:50:42 +0000</pubDate>
      <category>Health</category>
      <description>Ofer Shina, a 38-year-old Israeli product manager who carries an early-onset Alzheimer's gene, co-founded X-tosis in Gainesville, Florida, to develop a Ben-Gurion University drug candidate. The company has a $2.74 million Michael J. Fox Foundation grant and is targeting Parkinson's first. (2 outlets: 0 left · 1 centre · 1 right)</description>
      <media:content url="https://themedialine.org/wp-content/uploads/2026/11/magnific_expand_UPhiWXUwny.png" medium="image"/>
    </item>
  </channel>
</rss>
